Literature DB >> 22616617

Symptomatic and functional remission in patients with first-episode psychosis.

S Verma1, M Subramaniam, E Abdin, L Y Poon, S A Chong.   

Abstract

OBJECTIVE: For patients suffering from psychotic disorders and their caregivers, 'recovery' remains important. Our study aims to examine the rates of both symptomatic and functional remission in first-episode psychosis (FEP) patients at 2 years and identify sociodemographic and clinical factors associated with recovery.
METHOD: In this naturalistic study, all consecutive FEP patients presenting to an early psychosis intervention programme were recruited. Symptomatic remission was defined by the Schizophrenia Working Group's criteria; functional remission was defined as a Global Assessment of Functioning (GAF) disability score of ≥61 with engagement in age-appropriate vocation. Simple and multiple logistic regressions using stepwise method were used.
RESULTS: Out of 1175 patients, 636 (54.1%) met criteria for symptomatic remission, 686 (58.4%) for functional remission, while 345 (29.4%) met for both. Multiple logistic regression revealed female gender (OR 1.47; 95%CI, 1.12-1.93), those married (OR 1.49; 95%CI, 1.02-2.18), younger age (OR 0.98; 95%CI, 0.95-0.99), tertiary education (OR 1.56; 95%CI, 1.02-2.38), shorter DUP (OR 0.99; 95%CI, 0.98-0.99), lower baseline PANSS negative scores (OR 0.97; 95%CI, 0.95-0.99), and early response at month 3 (OR 1.78; 95%CI, 1.31-2.42), as significant predictors of recovery at year 2.
CONCLUSION: Our results indicate that strategies to reduce DUP and achieve early response could improve remission rates in FEP patients.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22616617     DOI: 10.1111/j.1600-0447.2012.01883.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  30 in total

1.  Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis.

Authors:  Ángel Del Rey-Mejías; David Fraguas; Covadonga M Díaz-Caneja; Laura Pina-Camacho; Josefina Castro-Fornieles; Inmaculada Baeza; Ana Espliego; Jessica Merchán-Naranjo; Ana González-Pinto; Elena de la Serna; Beatriz Payá; Montserrat Graell; Celso Arango; Mara Parellada
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-03-01       Impact factor: 4.785

2.  Untreated illness and recovery in clients of an early psychosis intervention program: a 10-year prospective cohort study.

Authors:  Gina Bhullar; Ross M G Norman; Neil Klar; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-29       Impact factor: 4.328

Review 3.  Relapse risk assessment in early phase psychosis: the search for a reliable and valid tool.

Authors:  Phil Tibbo; Ashok Malla; Rahul Manchanda; Richard Williams; Ridha Joober
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

4.  Predictors and Prevalence of Recovery and Remission for Consumers Discharged from Mental Hospitals in a Chinese Society.

Authors:  Daniel K W Young; Petrus Y N Ng; Jiayan Pan
Journal:  Psychiatr Q       Date:  2017-12

5.  Demographic correlates of attenuated positive psychotic symptoms.

Authors:  Rachel N Waford; Allison MacDonald; Katrina Goines; Derek M Novacek; Hanan D Trotman; Walker Elaine F; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Daniel H Mathalon; Ming T Tsuang; Diana O Perkins; Larry J Seidman; Scott W Woods; Thomas H McGlashan
Journal:  Schizophr Res       Date:  2015-05-18       Impact factor: 4.939

6.  Values in First-Episode Schizophrenia.

Authors:  Ofer Agid; Krysta Mcdonald; Gagan Fervaha; Romie Littrell; Jessica Thoma; Robert B Zipursky; George Foussias; Gary Remington
Journal:  Can J Psychiatry       Date:  2015-11       Impact factor: 4.356

7.  Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.

Authors:  Ditte L Vernal; Sandeep Kapoor; Aseel Al-Jadiri; Eva M Sheridan; Yehonathan Borenstein; Charles Mormando; Lisa David; Sukhbir Singh; Andrew J Seidman; Maren Carbon; Miriam Gerstenberg; Ema Saito; John M Kane; Hans-Christoph Steinhausen; Christoph U Correll
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-09       Impact factor: 2.576

8.  Longitudinal trajectory of early functional recovery in patients with first episode psychosis.

Authors:  Mei-Hua Hall; Kristina M Holton; Dost Öngür; Debra Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2019-02-28       Impact factor: 4.939

9.  Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains.

Authors:  Dana M Allswede; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon
Journal:  Am J Psychiatry       Date:  2019-09-06       Impact factor: 18.112

10.  Altered risky decision making in patients with early non-affective psychosis.

Authors:  Luk Msk; Chang Wc; Chong Csy; Siu Cmw; Chan Skw; Lee Emh; Hui Clm; Sun Yn; Lee Tmc; Lo Tl; Chen Eyh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-02-26       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.